HAE
Price
$79.80
Change
+$3.25 (+4.25%)
Updated
Sep 27 closing price
37 days until earnings call
WAT
Price
$357.33
Change
+$1.65 (+0.46%)
Updated
Sep 27 closing price
30 days until earnings call
Ad is loading...

HAE vs WAT

Header iconHAE vs WAT Comparison
Open Charts HAE vs WATBanner chart's image
Haemonetics
Price$79.80
Change+$3.25 (+4.25%)
Volume$933.01K
CapitalizationN/A
Waters
Price$357.33
Change+$1.65 (+0.46%)
Volume$689.5K
CapitalizationN/A
View a ticker or compare two or three
HAE vs WAT Comparison Chart
Loading...
HAE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
HAE vs. WAT commentary
Sep 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HAE is a StrongSell and WAT is a StrongBuy.

COMPARISON
Comparison
Sep 29, 2024
Stock price -- (HAE: $75.07 vs. WAT: $339.75)
Brand notoriety: HAE and WAT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: HAE: 108% vs. WAT: 64%
Market capitalization -- HAE: $4.33B vs. WAT: $20.38B
HAE [@Medical Specialties] is valued at $4.33B. WAT’s [@Medical Specialties] market capitalization is $20.38B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.77B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HAE’s FA Score shows that 0 FA rating(s) are green whileWAT’s FA Score has 2 green FA rating(s).

  • HAE’s FA Score: 0 green, 5 red.
  • WAT’s FA Score: 2 green, 3 red.
According to our system of comparison, WAT is a better buy in the long-term than HAE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HAE’s TA Score shows that 5 TA indicator(s) are bullish while WAT’s TA Score has 3 bullish TA indicator(s).

  • HAE’s TA Score: 5 bullish, 5 bearish.
  • WAT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, HAE is a better buy in the short-term than WAT.

Price Growth

HAE (@Medical Specialties) experienced а -2.11% price change this week, while WAT (@Medical Specialties) price change was +0.88% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.24%. For the same industry, the average monthly price growth was +3.13%, and the average quarterly price growth was +3.51%.

Reported Earning Dates

HAE is expected to report earnings on Nov 05, 2024.

WAT is expected to report earnings on Oct 29, 2024.

Industries' Descriptions

@Medical Specialties (-0.24% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
WAT($20.4B) has a higher market cap than HAE($4.34B). HAE has higher P/E ratio than WAT: HAE (34.47) vs WAT (31.78). WAT YTD gains are higher at: 3.195 vs. HAE (-12.209). WAT has higher annual earnings (EBITDA): 1B vs. HAE (264M). WAT has more cash in the bank: 396M vs. HAE (194M). HAE has less debt than WAT: HAE (871M) vs WAT (2.44B). WAT has higher revenues than HAE: WAT (2.96B) vs HAE (1.27B).
HAEWATHAE / WAT
Capitalization4.34B20.4B21%
EBITDA264M1B26%
Gain YTD-12.2093.195-382%
P/E Ratio34.4731.78108%
Revenue1.27B2.96B43%
Total Cash194M396M49%
Total Debt871M2.44B36%
FUNDAMENTALS RATINGS
HAE vs WAT: Fundamental Ratings
HAE
WAT
OUTLOOK RATING
1..100
5524
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
81
Overvalued
PROFIT vs RISK RATING
1..100
10045
SMR RATING
1..100
5915
PRICE GROWTH RATING
1..100
6446
P/E GROWTH RATING
1..100
5424
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HAE's Valuation (72) in the Medical Specialties industry is in the same range as WAT (81). This means that HAE’s stock grew similarly to WAT’s over the last 12 months.

WAT's Profit vs Risk Rating (45) in the Medical Specialties industry is somewhat better than the same rating for HAE (100). This means that WAT’s stock grew somewhat faster than HAE’s over the last 12 months.

WAT's SMR Rating (15) in the Medical Specialties industry is somewhat better than the same rating for HAE (59). This means that WAT’s stock grew somewhat faster than HAE’s over the last 12 months.

WAT's Price Growth Rating (46) in the Medical Specialties industry is in the same range as HAE (64). This means that WAT’s stock grew similarly to HAE’s over the last 12 months.

WAT's P/E Growth Rating (24) in the Medical Specialties industry is in the same range as HAE (54). This means that WAT’s stock grew similarly to HAE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HAEWAT
RSI
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Stochastic
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Momentum
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
MACD
ODDS (%)
Bearish Trend about 1 month ago
0%
N/A
TrendWeek
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
TrendMonth
ODDS (%)
Bearish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
Advances
ODDS (%)
Bullish Trend about 1 month ago
0%
N/A
Declines
ODDS (%)
Bearish Trend about 2 months ago
62%
Bearish Trend about 2 months ago
0%
BollingerBands
ODDS (%)
Bullish Trend about 1 month ago
0%
Bearish Trend about 1 month ago
0%
Aroon
ODDS (%)
Bullish Trend about 1 month ago
0%
Bullish Trend about 1 month ago
0%
View a ticker or compare two or three
Ad is loading...
HAE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
WAT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.14-0.28
-1.20%
GameStop Corp
TSLA210.60-3.51
-1.64%
Tesla
SPY552.08-11.60
-2.06%
SPDR® S&P 500® ETF Trust
AAPL222.77-6.23
-2.72%
Apple
BTC.X57431.023000-1681.457000
-2.84%
Bitcoin cryptocurrency

HAE and

Correlation & Price change

A.I.dvisor indicates that over the last year, HAE has been loosely correlated with A. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if HAE jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAE
1D Price
Change %
HAE100%
-0.67%
A - HAE
37%
Loosely correlated
-2.77%
OM - HAE
36%
Loosely correlated
-0.43%
WAT - HAE
36%
Loosely correlated
-1.91%
AXNX - HAE
36%
Loosely correlated
-0.01%
LIVN - HAE
35%
Loosely correlated
-1.61%
More

WAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WAT has been closely correlated with MTD. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if WAT jumps, then MTD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WAT
1D Price
Change %
WAT100%
-1.91%
MTD - WAT
75%
Closely correlated
-2.85%
TMO - WAT
70%
Closely correlated
-1.40%
BRKR - WAT
67%
Closely correlated
-2.19%
CRL - WAT
60%
Loosely correlated
-2.89%
BIO - WAT
58%
Loosely correlated
-0.89%
More